Greece’s PharOS has struck a deal with Teva’s Arrow Pharm and Malta Enterprise to acquire certain assets of Arrow Pharm in Malta for an undisclosed sum. “This agreement will enable PharOS to take over the factory building, equipment and human resources of Arrow Pharm,” stated Malta’s ministry for the economy, investment and small businesses. “The takeover transition will occur over the next few months, with PharOS expected to be operational in Ħal Far, Malta, by mid-2018.”
Noting that it would initially be manufacturing finished dosageformsin Ħal Far, the privately-owned Greek firm said it would “eventually extend...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?